Xenetic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.About XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.
CEOJames F. Parslow
CEOJames F. Parslow
Employees2
Employees2
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2011
Founded2011
Employees2
Employees2
XBIO Key Statistics
Market cap4.98M
Market cap4.98M
Price-Earnings ratio-1.03
Price-Earnings ratio-1.03
Dividend yield—
Dividend yield—
Average volume24.34K
Average volume24.34K
High today$2.17
High today$2.17
Low today$2.11
Low today$2.11
Open price$2.14
Open price$2.14
Volume6.99K
Volume6.99K
52 Week high$13.93
52 Week high$13.93
52 Week low$1.90
52 Week low$1.90
Stock Snapshot
As of today, Xenetic(XBIO) shares are valued at $2.16. The company's market cap stands at 4.98M, with a P/E ratio of -1.03.
On 2026-01-07, Xenetic(XBIO) stock traded between a low of $2.11 and a high of $2.17. Shares are currently priced at $2.16, which is +2.4% above the low and -0.5% below the high.
Xenetic(XBIO) shares are trading with a volume of 6.99K, against a daily average of 24.34K.
In the last year, Xenetic(XBIO) shares hit a 52-week high of $13.93 and a 52-week low of $1.90.
In the last year, Xenetic(XBIO) shares hit a 52-week high of $13.93 and a 52-week low of $1.90.
People also own
Based on the portfolios of people who own XBIO. This list is generated using Robinhood data, and it’s not a recommendation.